THE UTILITY OF SOX ANTIBODIES FOR CANCER PREDICTION IN PATIENTS WITH PARANEOPLASTIC NEUROLOGICAL DISORDERS

THE UTILITY OF SOX ANTIBODIES FOR CANCER PREDICTION IN PATIENTS WITH PARANEOPLASTIC NEUROLOGICAL DISORDERS

Bibliografski detalji
Glavni autori:	Maddison, P, Titulaer, M, Verschuuren, J, Gozzard, P, Lang, B, Willcox, N, Vincent, A, Irani, SR, Chapman, C
Format:	Conference item
Izdano:	2012

Slični predmeti

The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders
od: Maddison, P, i dr.
Izdano: (2018)

Antibodies associated with paraneoplastic neurological disorders.
od: Vincent, A
Izdano: (2005)

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies
od: Cristina Arnaldos-Pérez, i dr.
Izdano: (2023-05-01)

Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer.
od: Maddison, P, i dr.
Izdano: (2008)

Paraneoplastic neurological syndromes: a practical approach to diagnosis and management
od: Binks, S, i dr.
Izdano: (2021)

ANTI-HU PARANEOPLASTIC SENSORY NEURONOPATHY WITH UNDERLYING SQUAMOUS CELL CARCINOMA OF THE LUNG
od: Gozzard, P, i dr.
Izdano: (2010)

Recommended diagnostic criteria for paraneoplastic neurological syndromes.
od: Graus, F, i dr.
Izdano: (2004)

Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes.
od: Graus, F, i dr.
Izdano: (2005)

Review: Progress in the management of paraneoplastic neurological disorders
od: Hamid Sadeghian, i dr.
Izdano: (2010-01-01)

Paraneoplastic neurological syndromes. State of the art
od: Giometto, B, i dr.
Izdano: (2006)

Paraneoplastic neurological syndromes
od: Antoine Jean-Christophe, i dr.
Izdano: (2007-05-01)

Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations
od: Raquel Ruiz-García, i dr.
Izdano: (2019-04-01)

N-methyl-d-aspartate antibody encephalitis: Temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
od: Irani, SR, i dr.
Izdano: (2010)

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
od: Irani, SR, i dr.
Izdano: (2010)

Diagnosis of paraneoplastic neurological syndromes
od: Camilo E Fadul MD
Izdano: (2007-07-01)

Diagnosis of paraneoplastic neurological syndromes
od: Camilo E Fadul MD
Izdano: (2007-07-01)

PDE10A antibodies in autoimmune encephalitis: a possible marker of cancer immunotherapy?
od: Titulaer, MJ, i dr.
Izdano: (2019)

Antiganglioside antibodies and paraneoplastic neuromuscular junction disorder?
od: Noushin Jazebi, i dr.
Izdano: (2020-12-01)

EARLY AND CONTINUED TREATMENT OF N-METHYL D-ASPARTATE RECEPTOR-ANTIBODY ENCEPHALITIS OPTIMISES OUTCOME OF A PREDOMINANTLY NON-PARANEOPLASTIC DISEASE
od: Irani, SR, i dr.
Izdano: (2009)

An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes
od: Sai Wang, i dr.
Izdano: (2023-01-01)

Anti-Ma2-antibody-associated encephalitis: An atypical paraneoplastic neurologic syndrome
od: Bogna Targonska, i dr.
Izdano: (2018-05-01)

Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.
od: Paul Gozzard, i dr.
Izdano: (2015-01-01)

Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes
od: Daniel Chiu, i dr.
Izdano: (2023-07-01)

Neurological manifestation of cancer – paraneoplastic syndromes
od: Szklener Katarzyna, i dr.
Izdano: (2021-06-01)

Role of ion channel autoantibodies in NK-cell antibody-dependent anti-tumour immunity in patients with paraneoplastic Lambert-Eaton syndrome
od: Tschernatsch, M, i dr.
Izdano: (2009)

Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies
od: Jonas Feldheim, i dr.
Izdano: (2021-05-01)

Anti-Ma2 Antibody-Associated Paraneoplastic Neurological Syndromes: A Pilot Study
od: Yi Guo, i dr.
Izdano: (2021-11-01)

Antibody‐positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series
od: Sonja Kosek, i dr.
Izdano: (2024-05-01)

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
od: Irani, S, i dr.
Izdano: (2010)

Autoimmune and paraneoplastic seizures
od: Wagner, B, i dr.
Izdano: (2024)

Paraneoplastic neurologic syndrome: A practical approach
od: Sudheeran Kannoth
Izdano: (2012-01-01)

Ovarian Teratoma-Related Paraneoplastic Neurological Syndromes
od: Jingfang Lin, i dr.
Izdano: (2022-05-01)

Paraneoplastic neurological syndromes: clinical presentations and management
od: Michelle F. Devine, i dr.
Izdano: (2021-01-01)

Predicting disability and mortality in CV2/CRMP5‐IgG associated paraneoplastic neurologic disorders
od: Sanem P. Uysal, i dr.
Izdano: (2024-03-01)

A case of paraneoplastic neurological syndrome expressing dual antineuronal antibodies: Anti-hu and recoverin
od: Ho-Sung Ryu, i dr.
Izdano: (2020-01-01)

P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer.
od: Graus, F, i dr.
Izdano: (2002)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
od: Becker, E, i dr.
Izdano: (2012)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
od: Becker, E, i dr.
Izdano: (2012)

Thymoma and paraneoplastic myasthenia gravis.
od: Marx, A, i dr.
Izdano: (2010)

Clinical characteristics and immunotherapy response in paraneoplastic neurologic syndrome patients with increased number of high-risk antibodies
od: Gong Wang, i dr.
Izdano: (2025-01-01)